Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Neuromodulators Revenue	1.37B	1.29B
Fillers & Biostimulators Revenue	1.03B	1.01B
Injectable Aesthetics Revenue	2.40B	2.30B
Dermatological Skincare Revenue	1.38B	1.33B
Therapeutic Dermatology Revenue	881.00M	780.00M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
USA Revenue	1.92B	1.81B
International Revenue	2.73B	2.60B

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Neuromodulators Constant Currency Growth	11.80%
Fillers & Biostimulators Constant Currency Growth	7.00%
Injectable Aesthetics Constant Currency Growth	9.60%
Dermatological Skincare Constant Currency Growth	10.70%
Therapeutic Dermatology Constant Currency Growth	6.10%
Total Constant Currency Growth	9.30%

Updated Jun 30, 2025. Data Source: Fiscal.ai.